| GENPREX INC. NEW DL-,001 |
| USA |
| Gesundheit |
| US3724463027 / A41L3N |
| 2DE (Frankfurt) |
| FRA:2DE, ETR:2DE, 2DE:GR |
| - |
| https://www.genprex.com/ |
|
Genprex, Inc. is a clinical-stage biotechnology company specializing in gene therapy solutions for cancer and diabetes. Its core mission is to develop innovative therapies that deliver disease-fighting genes, aiming to offer novel options for patient..
>Volltext.. |
| 12.38 Mio. EUR |
| 11.42 Mio. EUR |
| - |
| -14.15 Mio. EUR |
| -14.53 Mio. EUR |
| -41.29 EUR |
| - |
| 0.96 Mio. EUR |
| -13.07 Mio. EUR |
| 0.43 |
| - |
| 26.16% |
| - |
| - |
| - |
| - |
| GENPREX |
| 05.04.26 |
|